Metropolis Healthcare has reported a strong performance in the fourth quarter, achieving 23% revenue growth and an impressive 70% margin increase. C Surendran, the Managing Director, attributed this success to a strategic focus on specialty and preventive healthcare, alongside the integration of four recently acquired entities. The company has observed a significant shift in diagnostics demand towards high-end specialty testing and preventive healthcare. Looking ahead, Metropolis anticipates a 14-15% compound annual growth rate (CAGR) in revenue over the next two to three years, with margins expected to stabilize at 27-28%. The integration of acquired businesses is nearly complete, with these entities currently contributing 8% to projected revenues for FY26. Surendran emphasized ongoing operational improvements and technology upgrades as key drivers of profitability and efficiency.